AS Latvijas Juras medicinas centrs Cash Flow-to-Debt Ratio
AS Latvijas Juras medicinas centrs cash flow-to-debt ratio. AS Latvijas Juras medicinas centrs (UOM) has a Cash Flow-to-Debt Ratio of -0.26x as of December 2025, meaning its operating cash flow of €-622.30K could theoretically repay 0% of its total liabilities (€2.40 Million) in one year. Check UOM cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of AS Latvijas Juras medicinas centrs (2015–2025)
Cash flow-to-debt ratio of AS Latvijas Juras medicinas centrs from 2015 to 2025. Historical debt coverage capacity for AS Latvijas Juras medicinas centrs across 11 annual periods. Check AS Latvijas Juras medicinas centrs (UOM) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
AS Latvijas Juras medicinas centrs Cash Flow-to-Debt Ratio by Year (2015–2025)
AS Latvijas Juras medicinas centrs cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for AS Latvijas Juras medicinas centrs. For the full cash flow conversion analysis, see AS Latvijas Juras medicinas centrs operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | €-17.28K | €2.40 Million | ▼ -103.4% |
| 2024 | 0.21x | €605.02K | €2.88 Million | ▼ -68.7% |
| 2023 | 0.67x | €1.91 Million | €2.85 Million | ▲ +25.3% |
| 2022 | 0.54x | €1.09 Million | €2.04 Million | ▲ +145.5% |
| 2021 | 0.22x | €418.24K | €1.92 Million | ▼ -45.5% |
| 2020 | 0.40x | €732.71K | €1.83 Million | ▲ +53.4% |
| 2019 | 0.26x | €412.86K | €1.58 Million | ▼ -31.3% |
| 2018 | 0.38x | €599.57K | €1.58 Million | ▲ +15.7% |
| 2017 | 0.33x | €478.41K | €1.46 Million | ▲ +34.0% |
| 2016 | 0.25x | €418.49K | €1.71 Million | ▲ +15.2% |
| 2015 | 0.21x | €362.36K | €1.70 Million | — |